Androgen Signaling Promotes Translation of TMEFF2 in Prostate Cancer Cells via Phosphorylation of the α Subunit of the Translation Initiation Factor 2-Reference-Cited by-同舟云学术

Androgen Signaling Promotes Translation of TMEFF2 in Prostate Cancer Cells via Phosphorylation of the α Subunit of the Translation Initiation Factor 2

Published:2013-02-06 Issue:2 Volume:8 Page:e55257
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Overcash Ryan F.,Chappell Vesna A.,Green Thomas,Geyer Christopher B.,Asch Adam S.,Ruiz-Echevarría Maria J.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference65 articles.

1. Androgen receptor in prostate cancer;CA Heinlein;Endocr Rev,2004

2. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer;Q Wang;Cell,2009

3. A very rapid effect of androgen on initiation of protein synthesis in prostate;T Liang;Proc Natl Acad Sci U S A,1975

4. Dihydrotestosterone and the initiation of protein synthesis by prostate ribosomes;T Liang;J Steroid Biochem,1975

5. Expression profiling the developing mammalian enteric nervous system identifies marker and candidate hirschsprung disease genes;TA Heanue;Proc Natl Acad Sci U S A,2006

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The dark side of mRNA translation and the translation machinery in glioblastoma;Frontiers in Cell and Developmental Biology;2023-03-13

2. The endoplasmic reticulum stress response in prostate cancer;Nature Reviews Urology;2022-09-27

3. Whole-Genome Sequencing of 100 Genomes Identifies a Distinctive Genetic Susceptibility Profile of Qatari Patients with Hypertension;Journal of Personalized Medicine;2022-04-29

4. The Androgen Hormone-Induced Increase in Androgen Receptor Protein Expression Is Caused by the Autoinduction of the Androgen Receptor Translational Activity;Current Issues in Molecular Biology;2022-01-25

5. (+)-JJ-74–138 is a Novel Noncompetitive Androgen Receptor Antagonist;Molecular Cancer Therapeutics;2022-01-20